林 博文

Medicine & Life Sciences

1. Colorectal Neoplasms 100%
2. Neoplasms 38%
3. Colonic Neoplasms 24%
4. Survival 18%
5. Heterogeneous-Nuclear Ribonucleoproteins 18%
6. Mucinous Adenocarcinoma 16%
7. Cell-Free Nucleic Acids 15%
8. Mutation 15%
9. Carcinogenesis 14%
10. High-Throughput Nucleotide Sequencing 12%
11. Class III Phosphatidylinositol 3-Kinases 11%
12. M Phase Cell Cycle Checkpoints 10%
13. 5' Untranslated Regions 10%
14. Hypoxia 10%
15. cathepsin S 9%
16. NADPH Oxidase 4 9%
17. regorafenib 9%
18. Pyruvate Dehydrogenase (Acetyl-Transferring) Kinase 9%
19. Pulmonary Infarction 9%
20. cdc Genes 9%
21. Colon 9%
22. Angiopoietins 9%
23. Rectal Fistula 8%
24. Epithelial Cells 8%
25. Metastasectomy 8%
26. Surgeons 8%
27. Epidermal Growth Factor 8%
28. Machine Learning 8%
29. Genes 8%
30. Messenger RNA 8%
31. Therapeutics 8%
32. Polyps 7%
33. Rectus Abdominis 7%
34. Capecitabine 7%
35. Drug Resistance 7%
36. Proctectomy 7%
37. Cell Cycle Proteins 7%
38. Cysteine Proteases 7%
39. human ERBB2 protein 7%
40. Rectal Neoplasms 7%
41. Leucovorin 7%